Controversies in Hypertension II: The Optimal Target Blood Pressure

Area of Science:

• Cardiology
• Nephrology
• Geriatrics

Background:

• The optimal blood pressure target for hypertension management is not definitively established.
• Current guidelines, such as the American recommendations of ≤130/80 mm Hg, are debated.
• Controversy exists regarding whether intensive blood pressure lowering offers superior benefits over standard targets (<140/90 mm Hg).

Purpose of the Study:

• To review existing clinical trials on intensive versus standard blood pressure lowering therapies.
• To analyze the heterogeneity in trial designs, patient populations, and endpoints.
• To discuss factors influencing individualized blood pressure targets.

Main Methods:

• Narrative review of at least 28 trials comparing more versus less intensive blood pressure therapy.
• Trials included those focused on cardiovascular events, mortality, chronic kidney disease, and surrogate endpoints.
• Analysis considered heterogeneity in chosen targets, studied populations, and primary endpoints.

Main Results:

• Most reviewed trials were negative, indicating no significant benefit from more intensive therapy.
• However, some trials demonstrated significant advantages of more intensive blood pressure reduction.
• Heterogeneity across studies complicates definitive conclusions.

Conclusions:

• Blood pressure control should be individualized, considering factors beyond general guidelines.
• Patient-specific elements like age, frailty, polypharmacy, and baseline blood pressure are critical.
• The diastolic blood pressure J-curve phenomenon necessitates careful consideration in treatment decisions.